Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Smoking Cessation 1 Renal Insufficiency 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Hepatitis B 1 Hematuria 1 Fatigue 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Dexamethasone 13 Bortezomib 8 Cyclophosphamide 6 Lenalidomide 5 pomalidomide 3 isatuximab 3 glucarpidase 3 Kidney Transplantation 3 Calcium Dobesilate 3 Thalidomide 2 Paclitaxel 2 Gemcitabine 2 Carboplatin 2 Blood Specimen Collection 2 Bendamustine Hydrochloride 2 Azacitidine 2 vinflunine 1 veliparib 1 trifluridine tipiracil drug combination 1 trebananib 1 safinamide 1 sacubitril and valsartan sodium hydrate drug combination 1 rubitecan 1 ripretinib 1 regorafenib 1 pevonedistat 1 pembrolizumab 1 osimertinib 1 mirabegron 1 melflufen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Renal Insufficiency × Urinalysis × Clear all

NCT04308642 2024-05-16

Kid-MaCareOnco

University Hospital, Basel, Switzerland

Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡